26.10.2023 • NewsTorayKoreaSGL Carbon

Toray Advanced Materials Break Ground on New Carbon Fiber Facility

Toray Advanced Materials Korea Inc. (TAK), the South Korean subsidiary of Japanese chemical giant Toray Group, broke ground on its new facility for carbon fiber production in Gumi, Korea.

Carbon fiber is used to make various products like high-pressure vessels for hydrogen, aircraft parts, racing car bodies, and golf club shafts. The new facility, which is TAK’s third unit for carbon fiber production, will increase the annual manufacturing capacity in Korea by 3,300 tons to 8,000 tons.

TAK produces special materials like films for industrial applications, carbon fibers, water treatment filters, and resin chemicals. It began operating the first unit of carbon fiber production in 2013. Established in 1972, TAK has invested more than $1 billion in manufacturing materials like engineering plastics, wallpapers, and car dash pads.

"TAK will create values with world-class technologies and qualities, while closely cooperating with partners and contributing to local economic revitalization", said CEO Jeon.

Toray Advanced Materials Korea breaks ground on the third unit of carbon fiber...
Toray Advanced Materials Korea breaks ground on the third unit of carbon fiber production in Gumi. © Toray

Company

Logo:

Toray Industries, Inc.

1-1, Nihonbashi-Muromachi 2-chome
Tokyo
Japan

Company contact







Virtual Event

Digitalization in the Chemical Industry
CHEManager Spotlight

Digitalization in the Chemical Industry

Save the Date: October 22, 2025
The event will be promoted to a combined audience of over 100,000 professionals across Europe through the CHEManager and CITplus networks.

Free Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

most read